婴儿发作综合征初始药物治疗的病因特异性亚组分析:单中心队列研究
Cemile Busra Olculu1, Seda Kanmaz1, Tugce Ince1
1Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkey.
概括
激素治疗,包括ACTH / 普雷迪尼索隆,为婴儿发作综合征 (IESS) 提供早期解决方案. 用维加巴和激素进行连续治疗可能会使特定的IESS亚组受益.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床药理学 临床药理学
背景情况:
- 婴儿发作综合征 (IESS) 是婴儿的一种严重综合征.
- 有效的初始药物治疗对于管理IESS和改善长期结果至关重要.
- 了解与不同治疗方式相关的电临床特征是必不可少的.
研究的目的:
- 评估婴儿发作综合征 (IESS) 初始药物治疗的疗效.
- 为了比较vigabatrin单一治疗,激素治疗和顺序治疗的电临床结果.
- 分析病因学对治疗反应和长期预后的影响.
主要方法:
- 一项对280名IESS患者进行的回顾性比较队列研究.
- 治疗组包括vigabatrin单一治疗,激素治疗 (ACTH / 普雷迪尼索隆) 和早期连续治疗 (vigabatrin + 激素在14天内).
- 评估的结果是短期 (停止,EEG解决) 和长期 (复发,演变为新综合征).
主要成果:
- 激素疗法 (ACTH / 普雷尼索隆) 显示显著提前IESS解决方案 (停止和EEG高节律症解决方案) (p=0.042).
- 与未知原因患者相比,患有明确病因的患者的复发率更高 (p=0.005).
- 具有遗传IESS病因的患者更有可能发展为新的综合征 (83.3%,p=0.039).
结论:
- 早期启动荷尔蒙疗法,特别是对维加巴的连续疗法,需要在明确的IESS子组中进行进一步的研究.
- 病因学在IESS预后和治疗反应中起着重要作用.
- 根据IESS病因来定制治疗策略,可能会改善长期的治疗结果.
更多相关视频
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.0K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.2K
相关概念视频
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:13Seizures: Classification
300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
01:29Spasmolytic Agents: Chemical Classification
853
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
853
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
233
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
233
01:14Antiepileptic Drugs: Glutamate Antagonists
276
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
276
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
320
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
320